Committees

ISCT Process Development & Manufacturing Committee

Charter

The Process Development & Manufacturing Committee strives to:

  • Establish and communicate best practices in Process Development & Manufacturing (PDM) as it relates to therapeutic cell-based products.
  • Assess emerging cell processing technologies and forecast their impact on the commercialization process.
  • Discuss critical product development regional, regulatory considerations

Projects & Objectives

  • Educational Webinars: Process Development is a discipline learned on the job and there are few texts that cover many of the best practices used in the field—and fewer available that discuss Cell Therapy-specific requirements. The Process and Product Development Subcommittee develops educational webinars to cover best practices in Cell Therapy Process Development. View upcoming webinars »
  • White papers: White papers are an important vehicle for the PPD to educate and influence the field. White papers will be published in peer-reviewed journals to increase the credibility and visibility of the PPD and ISCT. 
  • ISCT Annual Meeting: The PDM will be actively involved in the organization of the ISCT Annual Meeting. The Committee curates Roundtable sessions as part of the official ISCT Roundtable Program.

PDM Committee Working Groups

New to the PDM Committee in 2022 are topic-focused working groups. The working groups were established to provide individuals of the PDM the opportunity to dive deeper into specific manufacturing modules. 

The 2022 Committee

Headshot of Dominic Clarke

Co-Chair

Dominic Clarke, PhD

Discovery Life Sciences
United States

Headshot of John Fink

Chair

John Fink, MBA

Perkin Elmer
United States



Sasha Aleksic, MSc

FUJIFILM Irvine Scientific
United States

Julie Allickson, PhD, MSc, MT(ASCP)
Mayo Clinic
United States

Dirk Balshüsemann
Miltenyi
Germany

Christopher Bravery, PhD
Advanced Biologicals Ltd.
United Kingdom

Sonia Bulsara
Cytiva
United States

Emmanuelle Cameau
Pall Corporation
Europe

Mini Conjeevaram
Discovery Life Sciences
United States

Lindsay Davies
NextCell Pharma
Netherlands

Stephanie Davies
Valita Cell
Ireland

Mike Delahaye
AstraZeneca
Sweden

Nisha Durand, PhD
Mayo Clinic
United States

Shannon Eaker, PhD

XCell
United States

Maya Furstenau-Sharp, PhD
Sartorius-Stedim Biotech
Germany

Jeff Gilmore
cGMPnow
United States

Isaac Godfroy
Athersys
United States

Volker Huppert
Glycostem Therapeutics B.v.
Netherlands

Robert Jones
Cryoport
United Kingdom

Anne-Sophie Leburn
Bone Therapeutics
Belgium

Ru Li
West Pharmaceutical Sciences
United States

Matthew Marsh
Minaris
United States

Charlotte Morgan
Regeneus
Australia



Sam Molina, PhD
West Pharmaceutical Services
United States

Lisa O'Flynn
Avectas
Ireland

Steve Oh, PhD
ASTAR
Singapore

Jean-Sébastien Parisse, MBA
Aseptic Technologies
Belgium

Sebastian Rieck 
ViaCyte
United States

Janet Rothberg
CCRM
Canada

Robert Sassa
WL Gore & Associates
United States

Brianna Schoen, PhD
HemaCare, A Charles River Company
United States

Michael Scott, PhD
Novo Nordisk
United States

Dalip Sethi
Terumo
United States

David Smith
Ori Biotech
United States

Donald Singer
EcoLab, Bioquell
United States

John Tomtishen
Cellares
United States

Tim Tripp
Be The Match
United States

Joe Valdez
Berkeley Lights
United States

Robert Waters
Santen SA
United States

Sean Werner
BioLife/Sexton
United States

Bastian Westbomke
Arvato
United States

Yiyang Xu
Berkeley Lights
United States

Ezequiel Ztylberberg
Akron Biotech
United States